Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 20;10(1):1263.
doi: 10.1038/s41467-019-09249-z.

Axial shielding of Pd(II) complexes enables perfect stereoretention in Suzuki-Miyaura cross-coupling of Csp3 boronic acids

Affiliations

Axial shielding of Pd(II) complexes enables perfect stereoretention in Suzuki-Miyaura cross-coupling of Csp3 boronic acids

Jonathan W Lehmann et al. Nat Commun. .

Abstract

Stereocontrolled Csp3 cross-coupling can fundamentally change the types of chemical structures that can be mined for molecular functions. Although considerable progress in achieving the targeted chemical reactivity has been made, controlling stereochemistry in Csp3 cross-coupling remains challenging. Here we report that ligand-based axial shielding of Pd(II) complexes enables Suzuki-Miyaura cross-coupling of unactivated Csp3 boronic acids with perfect stereoretention. This approach leverages key differences in spatial orientation between competing pathways for stereoretentive and stereoinvertive transmetalation of Csp3 boronic acids to Pd(II). We show that axial shielding enables perfectly stereoretentive cross-coupling with a range of unactivated secondary Csp3 boronic acids, as well as the stereocontrolled synthesis of xylarinic acid B and all of its Csp3 stereoisomers. We expect these ligand design principles will broadly enable the continued search for practical and effective methods for stereospecific Csp3 cross-coupling.

PubMed Disclaimer

Conflict of interest statement

The University of Illinois has filed patent applications on ligands and methods reported in this manuscript, and some of these have been licensed to REVOLUTION Medicines, a company for which M.D.B. is a founder. All the remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Challenges in stereocontrolled Csp3 couplings. a Stereoselective couplings vs. stereospecific couplings. b Competing stereodivergent stereospecific transmetalation pathways. c Axial shielding—a ligand design principle for controlling stereochemistry in Csp3 couplings. Projecting steric bulk above and below the Pd (II) square plane should selectively inhibit stereoinvertive transmetalation, thus favoring stereoretention
Fig. 2
Fig. 2
Tuning of ligand sterics. a Crystal structure of {[(2-Me-Ph)3P]Pd(4-nBu-Ph)(Br)}2 and concept of blocking of the axial sites on Pd. b Model coupling reaction for optimizing ligands (ortho-substituent optimization) Pd(PPh3)4 was used due to insufficient yield with Pd2dba3/PPh3. c Crystal structure of {[(2-Bn-Ph)3P]Pd(4-OMe-Ph)(Br)}2 is consistent with the axial shielding ligand design principle. d % es and b/l ratio do not necessarily correlate as a function of ligand structure
Fig. 3
Fig. 3
Tuning of ligand electronics. The effect of ligand electronic tuning on stereooutcome and b/l ratio under both anhydrous (a) and biphasic (b) conditions (%branched = %b–%l). c Electronic tuning of L4 leads to perfect enantiospecificity for the cross-coupling of challenging substrate (S)-1a
Fig. 4
Fig. 4
Substrate scope of the sterospecific cross-coupling reaction. a Reaction conditions. b Scope of the Csp3 boronic acid coupling partner, (§: no improvement when using L2, *: branched on C3/branched on C2/linear (Supplementary Figure 5), #: L2 was used, L4 gave lower yields). c Scope of the bromide coupling partner. All reactions were performed in duplicate. Branched/linear ratios were determined by HPLC or GC analysis of the crude reaction using an authentic linear product standard. Yields were determined by isolation. Enantiospecificities were determined by chiral HPLC of the purified product
Fig. 5
Fig. 5
Building block-based synthesis of all possible Csp3 stereoisomers of xylarinic acid B. a Conditions for deprotection and coupling. b Air-stable BIDA boronate building blocks prepared by resolution. c Xylarinic acid B and all possible Csp3 steroisomers accessed by stereospecific cross-coupling of stereodefined building blocks. % ds, b/l, and yield refer to the cross-coupling step

References

    1. Blakemore DC, et al. Organic synthesis provides opportunities to transform drug discovery. Nat. Chem. 2018;10:383–394. doi: 10.1038/s41557-018-0021-z. - DOI - PubMed
    1. Choi J, Fu GC. Transition metal-catalyzed alkyl-alkyl bond formation. Another dimension in cross-coupling chemistry. Science. 2017;356:eaaf7230. doi: 10.1126/science.aaf7230. - DOI - PMC - PubMed
    1. Wang CY, Derosaa J, Biscoe MR. Configurationally stable, enantioenriched organometallic nucleophiles in stereospecific Pd-catalyzed cross-coupling reactions. An alternative approach to asymmetric synthesis. Chem. Sci. 2015;6:5105–5113. doi: 10.1039/C5SC01710F. - DOI - PMC - PubMed
    1. Cherney AH, Kadunce NT, Reisman SE. Enantioselective and enantiospecific transition-metal-catalyzed cross-coupling reactions of organometallic reagents to construct C-C bonds. Chem. Rev. 2015;115:9587–9652. doi: 10.1021/acs.chemrev.5b00162. - DOI - PMC - PubMed
    1. Harris MR, Hanna LE, Greene MA, Moore CE, Jarvo ER. Retention or inversion in stereospecific nickel-catalyzed cross-coupling of benzylic carbamates with arylboronic esters. Control of absolute stereochemistry with an achiral catalyst. J. Am. Chem. Soc. 2013;135:3303–3306. doi: 10.1021/ja311783k. - DOI - PMC - PubMed

Publication types